Golden Biotechnology Corporation (TPEX:4132)
Taiwan · Delayed Price · Currency is TWD 3.470
0.00 (0.00%)
Apr 9, 2026, 2:59 PM CST
Golden Biotechnology Market Cap
Golden Biotechnology has a market cap or net worth of 562.93 million as of April 20, 2026. Its market cap has decreased by -77.47% in one year.
Market Cap
562.93M
Enterprise Value
829.73M
Revenue
44.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.47
Market Cap Chart
Since May 26, 2010, Golden Biotechnology's market cap has decreased from 1.15B to 562.93M, a decrease of -50.92%. That is a compound annual growth rate of -4.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 562.93M | -85.57% |
| Dec 31, 2025 | 3.90B | 54.66% |
| Dec 31, 2024 | 2.52B | -54.81% |
| Dec 29, 2023 | 5.58B | -34.69% |
| Dec 30, 2022 | 8.55B | -50.08% |
| Dec 30, 2021 | 17.12B | 165.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InnoPharmax | 1.57B |
| Winston Medical Supply | 1.26B |
| DV Biomed | 1.24B |
| Excelsior Biopharma | 1.23B |
| Anxo Pharmaceutical | 1.17B |
| Prince Pharmaceutical | 1.12B |
| Original BioMedicals | 1.06B |
| Mediera | 1.02B |